Event-related potential changes in groups at increased risk for Alzheimer disease

Archives of Neurology

Volumn 56, Issue 11, 1999, Pages 1398-1403

  Green, Joanne ^a,b   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; EVENT RELATED POTENTIAL; HIGH RISK POPULATION; HUMAN; LATENT PERIOD; PRIORITY JOURNAL;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CASE-CONTROL STUDIES; EVOKED POTENTIALS; GENOTYPE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 0032726705     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.11.1398     Document Type: Article

References (39)

1. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early- and late-onset cases and among male and female relatives in successive generations. Neurology. 1988; 38:207-212.
2. Huff FJ, Auerbach J, Chakravarti A, Boiler F. Risk of dementia in relatives of patients with Alzheimer's disease. Neurology. 1988:38:786-790.
3. Mayeux R, Sano M, Chen J, Tatemichi T, Stern Y. Risk of dementia in firstdegree relatives of patients with Alzheimer's disease and related disorders. Arch Afa/roJ. 1991:48:269-273.
4. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993:261:921-923.
5. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Afeurotoffy. 1993:43:1467-1472.
6. Farrer L, Cupples L, van Diujn C, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neural. 1995:38:797-808.
7. Blacker D, Haines J, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 1997;48:139-147.
8. Bondi MW, Monsch AU, Galasko D, Butters N, Salmon DP, Delis DC. Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology. 1994; 8:374-384.
9. Horn J, Turner MB, Risser R, Bont FJ, Tintner R. Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients. J Clin Exp Neuropsyc/wJ. 1994:16:568-576.
10. Snowdon D, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: findings from the Nun Study. JAMA. 1996:275:528-532.
11. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 1995:273:942-947.
12. Reiman E, Caselli R, Yun L, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the t4 allele for apolipoprotein E. NEnglJMed. 1996; 334:752-758.
13. Sutton S, Braren M, Zubin J, John ER. Evoked potential correlates of stimulus uncertainty. Science. 1965:150:1187-1188.
14. Donchin E, Coles MGH. Is the P300 component a manifestation of context updating? Behav Brain Sei. 1988;11:357-374.
15. Smith ME, Halgren E, Sokolik M, et al. The intracranial topography of the P3 eventrelated potential elicited during auditory oddball. Electroencephalogr Clin Neurophysiol. 1990:76:235-248.
16. Tarkka IM, Stokic DS, Basile LFH, Papanicolaou AC. Electric source localization of the auditory P300 agrees with magnetic source localization. Electroencephalogr Clin fJeurophysiol. 1995:96:538-545.
17. Yamaguchi S, Knight RT. Anterior and posterior association cortex contributions to the somatosensory P300. J Neurosci. 1995;11:2039-2054.
18. Grady CL, Haxby JV, Horwitz B, et al. Longitudinal study of early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer's type. J Clin Exp Neuropsychol. 1988:10:576-596.
19. Haxby JV, Grady CL, Koss E, et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neural. 1990:47:753-760.
20. Kemper TL. Neuroanatomical and neuropathological changes during aging and dementia. In: Albert M, Knoefel JE, eds. Clinical Neurology o! Aging. 2nd ed. New York, NY: Oxford University Press Inc; 1994:3-67.
21. Gearing M, Mirra SS, Hedreen JC, Sumi SM. Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995:45(3, pt1):461-466.
22. Meador KJ, Loring DW, Davis HC, et al. Cholinergic and serotonergic effects on the P3 potential and recent memory. JClin Exp Neuropsychol. 1989:11:252260.
23. Marsh J, Schubarth G, Brown W, et al. PET and P300 relationships in early Alzheimer's disease. Neurobiol Aging. 1990:11:471-476.
24. Polich J, Ladish C, Bloom FE. P300 assessment of early Alzheimer's disease. Electroencephalogr Clin Neurophysiol. 1990:77:179-189.
25. Gearing M, Schneider J, Rebeck G, Hyman B, Mirra S. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology. 1990:45:1985-1990.
26. Green J, Woodard JL, Sirockman BE, et al. Event-related potential P3 change in mild Parkinson's disease. MovDisord. 1996:11:32-42.
27. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neural. 1991:48:278-281.
28. Albert M. Cognitive and neurobiologie markers of early Alzheimer disease. Proc NatlAcadSciUSA. 1996:93:13547-13551.
29. Delis DC, Kramer J, Kaplan E, Ober BA. The California Verbal Learning Test. San Antonio, Tex: Psychological Corp; 1986.
30. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, Tex: Psychological Corp; 1981.
31. Beck A. Beck Depression Inventory. San Antonio, Tex: Psychological Corp; 1987.
32. Pfefferbaum A, Ford J, Roth W, Kopell B. Age-related changes in auditory eventrelated potentials. E/ectroencephalogr Clin Neurophysiol. 1980:49:266-276.
33. Ritter W, Simson R, Vaughan H, Macht M. Manipulation of event-related potential manifestations of information processing stages. Science. 1982:218:909-911.
34. Donchin E. Presidential address, 1980: surprise... surprise? Psychophysiology. 1981;18:493-513.
35. Patterson JV, Michalewski HJ, Starr A. Latency variability of the components of auditory event-related potentials to infrequent stimuli in aging, Alzheimer-type dementia, and depression. Electroencephalogr Clin Neurophysiol. 1988:71:450-460.
36. Ball SS, Marsh JT, Schubarth G, Brown WS, Strandburg R. Longitudinal P300 latency changes in Alzheimer's disease. J Gerontol. 1989;44:M195-M200.
37. Verleger R, Kompf D, Neukater W. Event-related EEG potentials in mild dementia of the Alzheimer type. Electroencephalogr Clin Neurophysiol. 1992:84:332343.
38. Relkin N, Tanzi R, Breitner J, et al. Apolipoprotein E genotyping in Alzheimer's disease: National Institute on Aging/Alzheimer's Association Working Group. Lancet. 1996:347:1091-1095.
39. Boutros N, Torello MW, Burns EM, Wu SS, Nasrallah HA. Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry Res. 1995:57:57-63.